Hyperbilirubinemia Clinical Trial
Official title:
Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)(WS)(ISNHP)
The purpose of this protocol is to provide a mechanism to collect Long Term Clinical Data from those babies who participated in the primary Study 64,185-06-2(W)(WS)(ISNHP) "An Open-Label Study Of The Safety And Clinical Pharmacology Of Stanate® In Infants At-Risk For Exchange Transfusion".
The purpose of this protocol is to provide a mechanism to collect Clinical Data from those babies who participated in the primary Study 64,185-06-2(W)(WS)(ISNHP) "An Open-Label Study Of The Safety And Clinical Pharmacology Of Stanate® In Infants At-Risk For Exchange Transfusion". Data on long-term impact of Stannsoporfin on the physical, neurological, neurodevelopmental, biochemical, metabolic and hematopoietic profiles of the children will be collected at 9 and 18 months, 3, 6 and 9 years after Stannsoporfin administration ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00383318 -
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
|
N/A | |
| Completed |
NCT00360204 -
Improving Health Outcomes for New Mothers and Babies
|
Phase 3 | |
| Completed |
NCT00115544 -
Safety and Pharmacology of Stanate
|
Phase 2 | |
| Completed |
NCT01622699 -
Implementation of a Transcutaneous Bilirubinometer
|
N/A | |
| Terminated |
NCT00741117 -
Conjugated Hyperbilirubinemia and Pulse Oximetry
|
N/A | |
| Completed |
NCT00288600 -
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
|
Phase 4 | |
| Completed |
NCT02774434 -
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age
|
N/A | |
| Completed |
NCT01550627 -
Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy
|
Phase 0 | |
| Completed |
NCT00653874 -
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
|
Phase 3 | |
| Recruiting |
NCT03564678 -
Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia
|
Phase 2 | |
| Recruiting |
NCT04897113 -
Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
|
N/A | |
| Recruiting |
NCT01944696 -
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
|
N/A | |
| Completed |
NCT00635375 -
Comparative Study of Phototherapy for Hyperbilirubinemia
|
N/A | |
| Completed |
NCT03195998 -
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
|
||
| Completed |
NCT02446951 -
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
|
||
| Terminated |
NCT01136577 -
Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn
|
N/A | |
| Completed |
NCT04271098 -
The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries
|
||
| Completed |
NCT02691156 -
Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
|
||
| Completed |
NCT00004381 -
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
|
Phase 2 | |
| Completed |
NCT00004382 -
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
|
Phase 2 |